LX6171
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LX6171, covering 2010-03-03 to 2010-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment [Phase 2]